Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
Clinical trial NCT01488929 · COMPLETED
Trial details
- NCT number
- NCT01488929
- Sponsor
- Targacept Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-11-01
- Enrollment
- 603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.